Form 8-K - Current report:
SEC Accession No. 0001564590-17-012131
Filing Date
2017-06-05
Accepted
2017-06-05 17:15:30
Documents
1
Period of Report
2017-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20170601.htm 8-K 39187
  Complete submission text file 0001564590-17-012131.txt   40469
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 17892101
SIC: 2835 In Vitro & In Vivo Diagnostic Substances